Performance of D-dimer to lymphocyte ratio in predicting the mortality of COVID-19 patients

BACKGROUND: Nowadays, there is still no effective treatment developed for COVID-19, and early identification and supportive therapies are essential in reducing the morbidity and mortality of COVID-19. This is the first study to evaluate D-dimer to lymphocyte ratio (DLR) as a prognostic utility in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Fei, Yi, Qiong, Zhang, Quan, Deng, Jiayi, Li, Cheng, Xu, Min, Wu, Chenfang, Zhong, Yanjun, Wu, Shangjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797859/
https://www.ncbi.nlm.nih.gov/pubmed/36590587
http://dx.doi.org/10.3389/fcimb.2022.1053039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797859/
https://www.ncbi.nlm.nih.gov/pubmed/36590587
http://dx.doi.org/10.3389/fcimb.2022.1053039

Ejemplares similares